Andreas Katsanos Selected Research

Andreas Katsanos Research Topics

Disease

32	Glaucoma 04/2024 - 12/2008
19	Open-Angle Glaucoma (Glaucoma, Open Angle) 04/2024 - 01/2010
9	Exfoliation Syndrome 04/2024 - 01/2010
7	Ocular Hypertension (Glaucoma, Suspect) 04/2024 - 02/2011
5	Cataract (Cataracts) 04/2024 - 01/2015
4	Central Serous Chorioretinopathy 06/2022 - 02/2013
3	Blister (Bulla) 02/2023 - 04/2016
3	Hyperemia 12/2018 - 05/2013
2	Epiretinal Membrane (Epiretinal Membranes) 12/2022 - 01/2020
2	Astigmatism 01/2022 - 01/2017
2	Refractive Errors (Refractive Error) 01/2022 - 01/2019
2	Myopia 01/2019 - 05/2011
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2018
1	Low Tension Glaucoma 04/2024
1	Retinal Perforations 12/2022
1	Neuroinflammatory Diseases 09/2021
1	Toxic Optic Neuropathy 04/2021
1	Vision Disorders (Hemeralopia) 03/2021
1	Macular Edema 03/2021
1	Blindness (Hysterical Blindness) 07/2020
1	vitreous floaters 01/2020
1	Corneal Edema 09/2019
1	Aphakia 09/2019
1	Mydriasis 09/2019
1	Keratitis 09/2019
1	Keratoconus 01/2019
1	Ocular Hypotension 01/2018
1	Neovascular Glaucoma 01/2018
1	Cicatrix (Scar) 01/2018
1	Arthritis (Polyarthritis) 12/2017
1	Uveitis 12/2017
1	Siderosis 01/2017
1	Fibrosis (Cirrhosis) 04/2016
1	Acromegaly 07/2014

Drug/Important Bio-Agent (IBA)

10	Latanoprost (Xalatan)FDA Link 12/2023 - 09/2013
10	Timolol (Blocadren)FDA LinkGeneric 12/2023 - 02/2011
6	dorzolamide (Trusopt)FDA LinkGeneric 12/2023 - 01/2016
6	Retinaldehyde (Retinal)IBA 10/2021 - 12/2008
5	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 04/2022 - 05/2013
5	tafluprostIBA 01/2020 - 12/2013
4	SteroidsIBA 07/2020 - 05/2011
3	Fluorouracil (Carac)FDA LinkGeneric 02/2023 - 04/2016
3	Ophthalmic Solutions (Eye Drops)IBA 04/2022 - 05/2011
2	AntimetabolitesIBA 02/2023 - 09/2021
2	Verteporfin (Visudyne)FDA Link 06/2022 - 01/2022
2	ProstaglandinsIBA 01/2018 - 04/2015
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2018 - 05/2011
2	Travoprost (Travatan)FDA Link 01/2015 - 10/2014
1	hydroxide ionIBA 04/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2023
1	Antiglaucoma AgentsIBA 02/2023
1	microplasminIBA 03/2021
1	GlucocorticoidsIBA 07/2020
1	GATIBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	CollagenIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 11/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Vascular Endothelial Growth FactorsIBA 01/2018
1	EnzymesIBA 01/2018
1	Ranibizumab (Lucentis)FDA Link 01/2018
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2018
1	ImmunosorbentsIBA 01/2018
1	Endothelin-1 (Endothelin 1)IBA 01/2018
1	Antinuclear AntibodiesIBA 12/2017
1	IronIBA 01/2017
1	TabletsIBA 01/2017
1	ArgonIBA 01/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2014
1	Tissue Inhibitor of Metalloproteinase-4IBA 11/2013
1	Metalloproteases (Metalloproteinases)IBA 11/2013

Therapy/Procedure

11	Therapeutics 12/2023 - 05/2013
8	Trabeculectomy (Trabeculoplasty) 02/2023 - 12/2013
7	Lasers (Laser) 09/2021 - 09/2013
3	Phacoemulsification 04/2024 - 01/2018
3	Laser In Situ Keratomileusis (LASIK) 01/2022 - 05/2011
2	Intraocular Lens Implantation 04/2024 - 09/2019
2	Injections 02/2023 - 11/2017
2	Traction 12/2022 - 03/2021
2	Photochemotherapy (Photodynamic Therapy) 06/2022 - 01/2022
2	Slit Lamp 09/2019 - 04/2016
2	Cataract Extraction 01/2018 - 01/2017
2	Operative Surgical Procedures 01/2017 - 01/2016
1	Retreatment 01/2022
1	Intravitreal Injections 03/2021
1	Duration of Therapy 07/2020
1	Solid-State Lasers 01/2020
1	Vitrectomy 01/2020
1	Aftercare (After-Treatment) 12/2019
1	Intraocular Lenses (Intraocular Lens) 09/2019
1	Corneal Transplantation (Keratoplasty) 09/2019
1	Penetrating Keratoplasty 09/2019
1	Corneal Cross-Linking 09/2019
1	Light Coagulation 12/2018
1	Semiconductor Lasers 12/2018
1	Off-Label Use 01/2018
1	Filtering Surgery 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Glaucoma Drainage Implants 01/2017
1	Percutaneous Collagen Induction 04/2016